Global Clinical Trial Supplies Market to Grow at 6.5% During 2024-2032, Catalyzed by Expanding Biopharma Industry

June 11, 2020 | Healthcare

According to the latest report by IMARC Group, titled "Clinical Trial Supplies Market Report by Services (Product Manufacturing, Packaging, Labeling and Storage, Logistics and Distribution), Phase (Phase I, Phase II, Phase III, and Others), Therapeutic Area (Oncology, Cardiovascular Diseases, Respiratory Diseases, Central Nervous System (CNS) And Mental Disorders, and Others), End-Use Industry (Medical Device Industry, Biopharmaceuticals Industry, Pharmaceuticals Industry, and Others), and Region 2024-2032," the global clinical trial supplies market reached a value of US$ 2.5 Billion in 2023. Clinical trial supplies are designed for studying and recording observations during clinical research. The use of efficient supplies is crucial for conducting experiments on volunteers for numerous biomedical purposes. The medical trials are essential for studying the behavioral patterns of the subject upon exposure to novel drugs, vaccines, dietary supplements or medical equipment. They aid in estimating the safety and efficacy quotient of the novel treatment, which further assists in detecting, preventing and treating multiple ailments. They are also used to analyze the accuracy of a particular treatment method and in the diagnosis of various infectious and metabolic disorders. As a result, they are widely utilized across the healthcare sector for respiratory, oncological, cardiovascular and neurological applications.

Global Clinical Trial Supplies Market Trends:

The global market is primarily driven by the significant growth in the biopharmaceutical industry, along with the increasing number of clinical trials. These trails are pertinent to the development of effective treatment solutions for numerous chronic diseases, such as cancer and HIV. There has also been a considerable rise in the number of biologics and biosimilar drugs in trials for the development of innovative drug delivery systems, which is providing a thrust to the market growth. The market is further driven by the outbreak of the coronavirus disease (COVID-19) on the global level. This has escalated the number of clinical trials conducted for the development of novel vaccines and drugs to combat the mass transmission of the virus across the globe. On account of the highly infectious nature of this disease, significant investments are being made for conducting extensive research and development (R&D) activities by various governmental and non-governmental organizations to increase the frequency of clinical trials. Furthermore, the implementation of stricter handling requirements for numerous pharmaceutical products entering clinical trials has impelled the demand for improved supplies. Moreover, the growing inclination toward contract research organizations (CROs) for outsourcing research activities on a contractual basis is expected to increase the utilization of various trial supplies. Continual advancements in cold chain logistics and monitoring technologies are further contributing to the market growth. On account of the aforementioned factors, the market is projected to grow at a CAGR of 6.5% during 2024-2032.

Market Summary:

  • On the basis of the service, the market has been divided into product manufacturing, packaging, labeling and storage, and logistics and distribution.
  • Based on the phase, the market has been classified into phase I, phase II, phase III and others.
  • On the basis of the therapeutic area, the market has categorized into oncology, cardiovascular diseases, respiratory diseases, CNS and mental disorders, and others.
  • Based on the end use industry, the market has been segmented into medical device, biopharmaceuticals, pharmaceuticals and other industries.
  • On the geographical front, the market has been segregated into North America (the United States and Canada), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia and others), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia and others), Latin America (Brazil, Mexico and others), and Middle East and Africa.
  • The competitive landscape of the market has been studied in the report with the detailed profiles of the key players. Some of these players include Almac Group Ltd., Catalent Pharma Solutions Inc., DHL, Parexel, Thermo Fisher Scientific Inc., PCI Services, Sharp Clinical, Biocair, Movianto, etc.

Report Coverage:

Report Features Details
Base Year of the Analysis 2023
Historical Period 2018-2023
Forecast Period 2024-2032
Units US$ Billion
Segment Coverage Services, Phase, Therapeutic Area, End-Use Industry, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Almac Group Ltd., Catalent Pharma Solutions Inc., DHL, Parexel, Thermo Fisher Scientific Inc., PCI Services, Sharp Clinical, Biocair and Movianto
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)


About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

IMARC Group
30 N Gould St Ste R
Sheridan, WY 82801 USA
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800 |
Americas:- +1 631 791 1145 | Africa and Europe :- +44-753-713-2163 | Asia: +91-120-433-0800

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Global Clinical Trial Supplies Market to Grow at 6.5% During 2024-2032, Catalyzed by Expanding Biopharma Industry
Purchase options




Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us
UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More
KRISHAK BHARTI CO-OP LTD

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More
Stax

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More